Novo Nordisk (ADR)
Develops GLP-1 and insulin medicines for diabetes, obesity and rare diseases.
$45.60
After-hours close+0.00 (+0.00%)
At close$45.60(−1.43%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 7.36%Insiders —
Shares outstanding 4.44B · Float 3.17B · 71.5% free float
Institutions13F, as of Jun 30, 2026
1,448 holders · 326.93M shares · 220 new positions · 683 increased · 460 reduced · 141 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Dodge & Cox | 20.40M | 0.46% | +1.06M | Aug 13, 2026 |
| Loomis Sayles & Co L P | 18.59M | 0.42% | +1.58M | Aug 14, 2026 |
| Franklin Resources Inc | 13.04M | 0.29% | −3.04M | Aug 13, 2026 |
| Price T Rowe Associates Inc /MD/ | 11.70M | 0.26% | +644.0K | Aug 14, 2026 |
| Morgan Stanley | 11.66M | 0.26% | +790.7K | Aug 13, 2026 |
| Bank of America Corp /DE/ | 11.18M | 0.25% | +407.0K | Aug 14, 2026 |
| Capital International Investors | 9.72M | 0.22% | −2.07M | Aug 12, 2026 |
| Folketrygdfondet | 9.52M | 0.21% | +441.6K | Aug 13, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 5.20% | 177.80M | 13G | Apr 23, 2025 ↗ |
InsidersForm 4
Latest trades
Nothing filed in the last 12 months.
CongressHouse and Senate disclosures
Not reported.